These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 17241440)
1. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients. Campo J; Cano J; del Romero J; Hernando V; Rodríguez C; Bascones A Oral Dis; 2007 Jan; 13(1):110-6. PubMed ID: 17241440 [TBL] [Abstract][Full Text] [Related]
2. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM; J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
5. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City. Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063 [TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967 [TBL] [Abstract][Full Text] [Related]
7. Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients. Bonamigo RR; Borges K; Rietjens J; Arenzon S; Blanco LF; Loureiro R Int J Dermatol; 2004 Aug; 43(8):568-70. PubMed ID: 15304178 [TBL] [Abstract][Full Text] [Related]
8. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population. Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387 [TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397 [TBL] [Abstract][Full Text] [Related]
11. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection. Lascar RM; Gilson RJ; Lopes AR; Bertoletti A; Maini MK J Infect Dis; 2003 Dec; 188(12):1815-9. PubMed ID: 14673759 [TBL] [Abstract][Full Text] [Related]
12. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro. Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762 [TBL] [Abstract][Full Text] [Related]
13. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients. Miziara ID; Weber R Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726 [TBL] [Abstract][Full Text] [Related]
14. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088 [TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of hysterectomy in HIV-seropositive women compared to seronegative women. Franz J; Jamieson DJ; Randall H; Spann C Infect Dis Obstet Gynecol; 2005 Sep; 13(3):167-9. PubMed ID: 16126502 [TBL] [Abstract][Full Text] [Related]
17. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999 [TBL] [Abstract][Full Text] [Related]
18. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors. Luder E; Godfrey E; Godbold J; Simpson DM J Am Diet Assoc; 1995 Jun; 95(6):655-60. PubMed ID: 7759740 [TBL] [Abstract][Full Text] [Related]
19. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy? Jain MK; Opio CK; Osuagwu CC; Pillai R; Keiser P; Lee WM Clin Infect Dis; 2007 Apr; 44(7):996-1000. PubMed ID: 17342656 [TBL] [Abstract][Full Text] [Related]
20. Mode of HIV transmission associated with risk of oral lesions in HIV-infected subjects in Thailand. Nittayananta W; Chanowanna N; Winn T J Oral Pathol Med; 2010 Feb; 39(2):195-200. PubMed ID: 20002981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]